Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger
Jonel Trebicka

Showing results (121-130 of 971) with videos related to

Pageof 98
Sort By:
Alimentary Pharmacology & Therapeutics|April 17, 2025
Editorial: Carvedilol Remains the First-Line Treatment of Portal Hypertension After the CALIBRE TrialThomas Reiberger, Benedikt Simbrunner
Journal of Hepatology|October 23, 2024
Reply to: "Pyroptosis in liver failure: A twisted firestarter"Vlad Taru, Thomas Reiberger
Polish Journal of Radiology|February 27, 2019
AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal veinDaniel Kuetting, Karsten Wolter, Julian Luetkens, et al.
European Journal of Gastroenterology & Hepatology|October 6, 2011
Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shuntJonel Trebicka, Aleksander Krag, Stefan Gansweid, et al.
International Journal of Molecular Sciences|October 13, 2021
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic ImplicationsWolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 27, 2023
Role of endoscopy in hepatologyWim Laleman, Kai-Henrik Peiffer, Michael Tischendorf, et al.
JHEP Reports : Innovation in Hepatology|September 10, 2021
Reply to: "The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites"Michael Praktiknjo, Antonia Witt, Filippo Schepis, et al.
Frontiers in Oncology|December 17, 2021
The Role of Decorin and Biglycan Signaling in TumorigenesisValentina Diehl, Lisa Sophie Huber, Jonel Trebicka, et al.
International Journal of Molecular Sciences|September 13, 2025
IL-24 in COVID-19 Patients: Correlations with Disease ProgressionRichard Vollenberg, Katharina Schütte-Nütgen, Markus Strauss, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
Pageof 98

Showing results (121-130 of 971) with videos related to

Sort By:
Pageof 98
Alimentary Pharmacology & Therapeutics|April 17, 2025
Editorial: Carvedilol Remains the First-Line Treatment of Portal Hypertension After the CALIBRE TrialThomas Reiberger, Benedikt Simbrunner
Journal of Hepatology|October 23, 2024
Reply to: "Pyroptosis in liver failure: A twisted firestarter"Vlad Taru, Thomas Reiberger
Polish Journal of Radiology|February 27, 2019
AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal veinDaniel Kuetting, Karsten Wolter, Julian Luetkens, et al.
European Journal of Gastroenterology & Hepatology|October 6, 2011
Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shuntJonel Trebicka, Aleksander Krag, Stefan Gansweid, et al.
International Journal of Molecular Sciences|October 13, 2021
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic ImplicationsWolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 27, 2023
Role of endoscopy in hepatologyWim Laleman, Kai-Henrik Peiffer, Michael Tischendorf, et al.
JHEP Reports : Innovation in Hepatology|September 10, 2021
Reply to: "The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites"Michael Praktiknjo, Antonia Witt, Filippo Schepis, et al.
Frontiers in Oncology|December 17, 2021
The Role of Decorin and Biglycan Signaling in TumorigenesisValentina Diehl, Lisa Sophie Huber, Jonel Trebicka, et al.
International Journal of Molecular Sciences|September 13, 2025
IL-24 in COVID-19 Patients: Correlations with Disease ProgressionRichard Vollenberg, Katharina Schütte-Nütgen, Markus Strauss, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
Pageof 98